Mariagrazia Distefano Selected Research

Uterine Cervical Neoplasms (Cancer of the Cervix)

1/2019	Dose-dense paclitaxel/carboplatin as neo-adjuvant chemotherapy followed by radical surgery in locally advanced cervical cancer: a prospective phase II study.
12/2017	Could lymphadenectomy be avoided in locally advanced cervical cancer patients administered preoperative chemoradiation? A large-scale retrospective study.
10/2008	Quality of life and psychological distress in locally advanced cervical cancer patients administered pre-operative chemoradiotherapy.
4/2007	Carboplatin-based neoadjuvant treatment with peripheral blood stem cell and growth factor support in locally advanced cervical cancer patients with bulky metastatic lymph nodes.
3/2007	Lymph node involvement in locally advanced cervical cancer patients administered preoperative chemoradiation versus chemotherapy.
2/2007	Expression of class III beta tubulin in cervical cancer patients administered preoperative radiochemotherapy: correlation with response to treatment and clinical outcome.
9/2004	Frozen section examination of pelvic lymph nodes in endometrial and cervical cancer: accuracy in patients submitted to neoadjuvant treatments.
1/2004	Concomitant radiochemotherapy plus surgery in locally advanced cervical cancer: update of clinical outcome and cyclooxygenase-2 as predictor of treatment susceptibility.
3/2002	Neoadjuvant treatment of locally advanced carcinoma of the uterine cervix with epirubicin, paclitaxel and cisplatin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mariagrazia Distefano Research Topics

Disease

9	Ovarian Neoplasms (Ovarian Cancer) 05/2023 - 07/2003
9	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2019 - 03/2002
6	Neoplasms (Cancer) 05/2023 - 02/2002
3	Carcinoma (Carcinomatosis) 11/2006 - 03/2002
2	Ovarian Epithelial Carcinoma 01/2022 - 01/2020
1	Thrombosis (Thrombus) 05/2023
1	COVID-19 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Infections 01/2021
1	Anemia 11/2006
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2003
1	Leukopenia 03/2002

Drug/Important Bio-Agent (IBA)

5	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 03/2002
4	PlatinumIBA 01/2022 - 01/2017
3	Bevacizumab (Avastin)FDA Link 10/2021 - 01/2020
3	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 04/2007
2	Cisplatin (Platino)FDA LinkGeneric 03/2002 - 02/2002
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2022
1	Antihypertensive Agents (Antihypertensives)IBA 01/2021
1	TrabectedinIBA 01/2017
1	liposomal doxorubicin (Doxil)FDA Link 01/2017
1	1-dodecylpyridoxal (PLD)IBA 01/2017
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2014
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2007
1	TubulinIBA 02/2007
1	hemoglobin ASIBA 11/2006
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2004
1	Proteins (Proteins, Gene)FDA Link 07/2003
1	Antineoplastic Agents (Antineoplastics)IBA 03/2003
1	DNA (Deoxyribonucleic Acid)IBA 03/2003
1	taxaneIBA 03/2003
1	Taxoids (Taxanes)IBA 03/2003
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 03/2002
1	Epirubicin (Ellence)FDA LinkGeneric 03/2002
1	FlavonoidsIBA 02/2002
1	IdB 1016IBA 02/2002
1	Silybin (Lagosa)IBA 02/2002

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 05/2023 - 05/2005
5	Neoadjuvant Therapy 01/2022 - 03/2002
4	Chemoradiotherapy 10/2008 - 01/2004
2	Therapeutics 10/2021 - 03/2003
1	Catheters 05/2023
1	Cytoreduction Surgical Procedures 01/2022
1	Aftercare (After-Treatment) 01/2022
1	Continuity of Patient Care 01/2021
1	Adjuvant Chemotherapy 01/2019
1	Lymph Node Excision (Lymph Node Dissection) 12/2017
1	Salvage Therapy 12/2014